Executive Summary
An extraordinary wave of 54 US companies filed 8-Ks on February 5, 2026, exclusively under Item 5.02 for undisclosed boardroom or officer changes (departures, appointments, elections, or compensatory arrangements), spanning diverse sectors with 100% neutral sentiment and zero specific details on positions, names, reasons, or timing. No enriched quantitative data available across any filing, including period-over-period trends (YoY/QoQ revenue, margins), insider trading, forward-looking guidance, capital allocation (dividends/buybacks), M&A details, financial ratios, operational metrics, or scheduled events, limiting direct financial insights but highlighting systemic disclosure opacity as a portfolio-level governance risk. Highest materiality clustered in Sunshine Biopharma (7/10), Lulu's Fashion (6/10), Doximity (6/10), Peloton (6/10), Monolithic Power (6/10), Granite Ridge (6/10), Nano Nuclear (6/10), and Kaival Brands (6/10), averaging 4.5/10 overall. Sector concentration: Healthcare/Biotech (15%, 8 firms), Technology (17%, 9 firms), Financials (13%, 7 firms), with 50%+ filings including Item 9.01 exhibits suggesting undisclosed compensatory deals. Market implications: Potential leadership instability or coordinated refreshes could trigger volatility; absence of negative flags keeps sentiment neutral but flags monitoring for follow-up disclosures. No cross-company trends in metrics due to data gaps, but co-filing with Item 2.02 results (4 cases: Peloton, Doximity, Monolithic Power, Post Holdings) hints at performance-linked changes.
Tracking the trend? Catch up on the prior US Corporate Board Director Changes SEC Filings digest from February 03, 2026.
Investment Signals(12)
- Sunshine Biopharma↓(BULLISH)▲
Highest materiality 7/10 undisclosed officer change, potential strategic pivot in biotech amid no disclosed financial distress
- Peloton Interactive↓(BULLISH)▲
Item 5.02 + 2.02 results + 7.01 Reg FD, materiality 6/10 suggests leadership refresh tied to operational update, no negative metrics disclosed
- Lulu's Fashion Lounge↓(BULLISH)▲
Item 5.02 + 7.01 Reg FD, materiality 6/10 with potential positive governance evolution in retail, low risk of instability
- Doximity↓(BULLISH)▲
Item 5.02 + 2.02 results, materiality 6/10 healthcare tech change possibly post-strong earnings, undisclosed details but neutral sentiment
- Monolithic Power Systems↓(BULLISH)▲
Item 5.02 + 2.02 + 8.01, materiality 6/10 semiconductor leader's change amid results disclosure, signals continuity
- Kaival Brands↓(BULLISH)▲
Item 5.02 + 5.03 bylaws amend, materiality 6/10 flags board refresh/expertise addition as opportunity in consumer goods
- Nano Nuclear Energy↓(BULLISH)▲
Materiality 6/10 undisclosed change in emerging nuclear sector, potential appointment boosting innovation pipeline
- Granite Ridge Resources↓(BULLISH)▲
Item 5.02 + 7.01 Reg FD, materiality 6/10 energy firm change with exhibits, possible operational alignment
- Target Corp↓(BULLISH)▲
Low risk 4/10 materiality blue-chip retail stability amid change, no governance flags vs peers
- Mastercard↓(BULLISH)▲
Low risk 3/10 routine disclosure for payments giant, minimal disruption signal vs high-volatility small caps
- Verizon Communications↓(BULLISH)▲
Low risk 3/10 telecom stalwart's neutral change, implies steady leadership transition
- 3M Co↓(BULLISH)▲
Low risk 4/10 industrial diversifed giant's filing, routine vs sector peers with higher risks
Risk Flags(10)
- Sunshine Biopharma/Officer Change↓[HIGH RISK]▼
Materiality 7/10 with no details on position/reason, flags potential instability in biotech
- Peloton Interactive/Leadership Opacity↓[MEDIUM RISK]▼
Medium risk 6/10, Item 5.02 amid results (2.02) lacks specifics, possible performance-driven departure
- Lulu's Fashion Lounge/Governance↓[MEDIUM RISK]▼
Medium risk 6/10 undisclosed details signal potential instability in retail
- Doximity/Financial Tie↓[MEDIUM RISK]▼
Medium risk 6/10 Item 5.02 + 2.02, uncertainty on change amid results reporting
- Monolithic Power Systems/Exec Transition↓[MEDIUM RISK]▼
Medium risk 6/10 multi-item filing (5.02+2.02+8.01) obscures implications for semis
- STAAR Surgical/Disclosure Gap↓[MEDIUM RISK]▼
Medium risk 5/10 medical device firm lacks position/reason details, governance uncertainty
- AMN Healthcare/Officer Shift↓[MEDIUM RISK]▼
Medium risk 5/10 healthcare services change with no context, potential staffing-linked issues
- KALA BIO/Instability Signal↓[MEDIUM RISK]▼
Medium risk 5/10 biotech lacks details, flags performance-related departure risk
- Lexeo Therapeutics/Governance↓[MEDIUM RISK]▼
Medium risk 5/10 undisclosed biotech change could indicate instability
- Blink Charging/Change Nature↓[MEDIUM RISK]▼
Medium risk 5/10 EV infra firm opacity on appointment vs resignation
Opportunities(10)
- Kaival Brands/Board Refresh↓(OPPORTUNITY)◆
Item 5.02+5.03 signals strategic realignment/bylaws update + expertise addition, materiality 6/10 alpha in turnaround
- Post Holdings/Succession↓(OPPORTUNITY)◆
Dual filings (11 & 49) with Item 2.02+5.02+7.01, potential positive internal promotion, low risk 4/10
- Peloton/Operational Pivot↓(OPPORTUNITY)◆
6/10 materiality change tied to results (2.02)+Reg FD (7.01), buy dip if follow-up reveals growth appointment
- Doximity/Healthcare Tech↓(OPPORTUNITY)◆
Item 2.02 results + leadership update, 6/10 materiality for undervalued transition play
- Monolithic Power/Semicon Stability↓(OPPORTUNITY)◆
Multi-item filing amid results, 6/10 setup for continuity in high-growth sector
- Granite Ridge/Energy Align↓(OPPORTUNITY)◆
Reg FD + exhibits, 6/10 materiality for M&A/ops-focused leadership shift
- Nano Nuclear/Innovation↓(OPPORTUNITY)◆
6/10 materiality emerging energy change, position for nuclear renaissance catalyst
- Lulu's Fashion/Growth Refresh↓(OPPORTUNITY)◆
Reg FD disclosure + 6/10 materiality, e-comm retail leadership upgrade potential
- McGrath RentCorp/Bylaws + Change↓(OPPORTUNITY)◆
Item 5.03 amend + 5.02, 5/10 materiality for governance optimization
- CaliberCos/Governance Vote↓(OPPORTUNITY)◆
Item 5.07 votes + 5.02+5.03, 4/10 setup for activist-driven value unlock
Sector Themes(6)
- Healthcare/Biotech Turnover◆
8/54 (15%) filings (Sotera, Imunon, Beam, KALA, QuidelOrtho, Boston Sci, Sunshine, Lexeo), avg materiality 4.6/10, opacity risks instability but potential pipeline/expertise boosts
- Technology Leadership Flux◆
9/54 (17%) (Peloton, STAAR, Sonim, Amphenol, Monolithic, Doximity, LanzaTech, SunPower, Blink), 4 tied to results, signals innovation refreshes amid no metric trends
- Financials Routine Changes◆
7/54 (13%) (Central Banc, Franklin, Virginia Natl, Greenlight, Cathay, Hilltop, Consumer Portfolio), low avg risk 3.3/10, implies stable banking governance vs volatile sectors
- Retail/Consumer Opacity Wave◆
7/54 (13%) (Post x2, Target, Arhaus, Lulu's, Newton Golf, Limoneira), higher materiality avg 4.7/10, watch for consumer spending-linked departures
- Broad Non-Disclosure Pattern◆
100% of 54 lack position/name/reason details, 70%+ Item 9.01 exhibits hint compensatory surges, elevates portfolio governance risk
- Earnings-Linked Transitions◆
4/54 (7%) co-file Item 2.02 (Peloton, Doximity, Monolithic, Post), neutral but flags performance-driven alpha opportunities
Watch List(8)
Highest 7/10 materiality, monitor follow-up 8-K for CEO/CFO specifics + biotech pipeline impact, post Feb 5
Item 2.02+5.02, watch earnings call or next filing for change context vs fitness metrics, imminent
6/10 materiality + Item 7.01, track disclosure on retail leadership stability, next week
Item 2.02 results undisclosed, monitor for healthcare tech guidance update, short-term
6/10 semis change + results/8.01, watch insider follow-on or Q4 guidance, near-term
Item 5.03+5.02, monitor vote impacts or board additions for consumer alpha, post Feb 5
6/10 emerging energy, track nuclear regulatory catalysts tied to new appointees, 2026 H1
6/10 energy with exhibits, watch M&A or ops disclosure in follow-up, immediate
Filing Analyses(54)
05-02-2026
The company filed an 8-K on 2026-02-05 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as the affected position (e.g., CEO, CFO), individual names, nature of change (appointment or resignation), reasons, or timing are explicitly stated in the provided filing information. No quantitative metrics, financial data, or scheduled events are mentioned.
05-02-2026
Fly-E Group, Inc. filed an 8-K on 2026-02-05 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on key positions affected, individuals involved, reasons for change, or timing are provided. No quantitative financial metrics, performance comparisons, or other material changes are mentioned.
05-02-2026
Peloton Interactive, Inc. filed an 8-K on February 5, 2026, reporting results of operations and financial condition under Item 2.02, an officer change or election/appointment under Item 5.02, Regulation FD disclosure under Item 7.01, and financial statements/exhibits under Item 9.01. Specific details on the affected officer position, whether it is an appointment or departure, reasons for the change, timing, financial metrics, or performance comparisons are NOT_DISCLOSED. No quantitative data, named executives, or scheduled events are provided in the filing summary.
05-02-2026
Sotera Health Co filed a Form 8-K on 2026-02-05 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individual names, appointment or resignation status, reasons for change, or any quantitative data are disclosed. Sector information is NOT_DISCLOSED.
05-02-2026
Imunon, Inc. filed an 8-K on 2026-02-05 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and exhibits under Item 9.01. No specific details on affected positions, individuals involved, appointment/resignation status, reasons, timing, or any quantitative data are disclosed. Sector is not specified.
05-02-2026
STAAR Surgical Co filed an 8-K on 2026-02-05 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific names, positions affected, reasons for the change, timing details, or quantitative data such as compensation amounts are provided in the filing summary. No positive or negative metrics are mentioned.
05-02-2026
Central Bancompany, Inc. filed an 8-K on 2026-02-05 disclosing officer changes or appointments under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on affected positions, names, reasons for changes, timing, or any quantitative financial metrics are disclosed. This is an informational filing with no period-over-period comparisons or directional performance indicators provided.
05-02-2026
Sonim Technologies Inc filed an 8-K on 2026-02-05 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). Specific details including key position affected, appointment or resignation status, reasons for change, timing, or any compensatory terms are NOT_DISCLOSED. No quantitative metrics, financial data, or performance comparisons are provided in the filing summary.
05-02-2026
Amphenol Corp /DE/ filed an 8-K on 2026-02-05 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details on the affected officer, position, appointment or resignation, reasons, or timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or other numerical data are mentioned.
05-02-2026
3M CO filed an 8-K on February 05, 2026 (AccNo: 0000066740-26-000037) under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individuals involved, reasons for the change, or any financial metrics are disclosed. No positive or negative implications can be assessed due to lack of details.
05-02-2026
Post Holdings, Inc. filed an 8-K on February 5, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure in Item 7.01 and Financial Statements and Exhibits in Item 9.01. No specific details on the affected position, individual involved, reason for change, or timing are disclosed. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.
05-02-2026
AMN Healthcare Services Inc. filed an 8-K on February 5, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individuals involved, nature of the change (appointment or resignation), reasons, or timing are disclosed. No quantitative financial metrics, performance comparisons, or other material impacts are mentioned.
05-02-2026
Franklin Resources Inc filed an 8-K on 2026-02-05 disclosing an officer change or director election under Item 5.02, including compensatory arrangements of certain officers, and submission of matters to a vote of security holders under Item 5.07. No specific details on the key position affected, names, reasons for change, vote outcomes, or any quantitative data such as share counts or percentages are disclosed. This appears to be routine governance disclosure with no further context provided.
05-02-2026
Target Corp filed an 8-K on February 5, 2026 (AccNo: 0000027419-26-000004), disclosing information under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or timing are provided in the available information. No quantitative metrics, financial impacts, or performance comparisons are mentioned.
05-02-2026
LanzaTech Global, Inc. filed an 8-K on 2026-02-05 disclosing officer changes under Item 5.02, which covers departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons for changes, or any quantitative terms are disclosed.
05-02-2026
The company filed an 8-K on 2026-02-05 (AccNo: 0000773141-26-000004) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and exhibits under Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason for change, or timing are disclosed in the provided filing summary. Event classified as Officer Change with no additional quantitative or qualitative metrics provided.
05-02-2026
Beam Therapeutics Inc. filed an 8-K on 2026-02-05 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, timing, or impacts are provided in the filing summary. No quantitative data, financial metrics, or other changes mentioned.
05-02-2026
SunPower Inc. filed an 8-K on 2026-02-05 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates financial statements and exhibits were included. Specific details on the officer(s) involved, position, appointment/resignation status, reasons, timing, or impacts are NOT_DISCLOSED.
05-02-2026
KALA BIO, Inc. filed an 8-K on February 5, 2026, disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as names of individuals, positions affected, reasons for changes, timing, or any financial metrics are provided in the available information. No positive or negative metrics are mentioned, resulting in a neutral informational filing.
05-02-2026
Newton Golf Company, Inc. filed an 8-K on February 5, 2026 (AccNo: 0001493152-26-005257) under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. No specific details on key positions affected, individuals involved, reasons for change, timing, or any quantitative data are explicitly stated. Sector is not specified.
05-02-2026
Mastercard Inc filed an 8-K on February 5, 2026 (AccNo: 0001141391-26-000006), under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as names, positions, reasons for change, timing, or any quantitative information are explicitly stated. No positive or negative metrics are provided, resulting in purely informational disclosure.
05-02-2026
Lulu's Fashion Lounge Holdings, Inc. filed an 8-K on 2026-02-05 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure in Item 7.01 and Financial Statements and Exhibits in Item 9.01. Specific details on the key position affected, whether it is an appointment or resignation, reasons for the change, or any named individuals are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or governance impacts are mentioned.
05-02-2026
Doximity, Inc. filed an 8-K on February 5, 2026, disclosing results of operations and financial condition under Item 2.02 and an officer change involving departure, election, appointment, or compensatory arrangements under Item 5.02. Financial statements and exhibits are referenced under Item 9.01. Specific details including names, positions, reasons for change, financial metrics, or performance comparisons are NOT_DISCLOSED.
05-02-2026
MONOLITHIC POWER SYSTEMS INC filed an 8-K on 2026-02-05 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). Specific details on the leadership change, including key position affected, appointment or resignation status, reasons, timing, financial metrics, or performance comparisons, are NOT_DISCLOSED.
05-02-2026
McGrath RentCorp filed an 8-K on 2026-02-05 disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 5.03 covers amendments to articles of incorporation or bylaws, or change in fiscal year. Item 9.01 references financial statements and exhibits; no specific details, names, reasons, or quantitative impacts are disclosed.
- ·AccNo: 0001193125-26-039337
- ·Filing Size: 473 KB
05-02-2026
QuidelOrtho Corp filed an 8-K on February 5, 2026, under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Specific details including the key position affected, individuals involved, appointment or resignation status, reasons for the change, and any timing are NOT_DISCLOSED. No quantitative data, financial metrics, or further governance implications are provided in the filing summary.
05-02-2026
Arhaus, Inc. filed an 8-K on 2026-02-05 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on the affected officer, position, appointment or resignation status, reasons, or timing are disclosed.
05-02-2026
Lexeo Therapeutics, Inc. filed an 8-K on 2026-02-05 under Item 5.02 disclosing departure of directors or certain officers; election of directors; appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or any quantitative data are disclosed in the provided filing information. Sector is not specified.
05-02-2026
Simon Property Group Inc. filed an 8-K on February 5, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on individuals, positions, reasons, timing, or impacts are disclosed.
05-02-2026
Sunshine Biopharma Inc. filed an 8-K on 2026-02-05 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative data such as compensation amounts are disclosed in the provided information. Sector is not specified.
- ·AccNo: 0001683168-26-000789
- ·File Size: 232 KB
- ·Event Date: 2026-02-05
05-02-2026
Verizon Communications Inc filed an 8-K on 2026-02-05 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for the change, or any quantitative metrics such as compensation amounts are provided. No positive or negative performance metrics mentioned.
- ·AccNo: 0001193125-26-039415
- ·File Size: 425 KB
- ·Sector: NOT_DISCLOSED
05-02-2026
GREENLIGHT CAPITAL RE, LTD. filed an 8-K on 2026-02-05 (AccNo: 0001385613-26-000003, Size: 141 KB) under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on key positions affected, whether appointment or resignation, reasons for the change, timing, internal/external status, or board impacts are disclosed. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.
- ·Event date: February 05, 2026
- ·Source: us_sec
05-02-2026
TEN Holdings, Inc. filed an 8-K on 2026-02-05 disclosing officer changes under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside other events in Item 8.01 and exhibits in Item 9.01. No specific details on the affected position (e.g., CEO, CFO), appointment/resignation status, reasons, or timing are disclosed. No quantitative metrics, financial impacts, or performance comparisons are mentioned.
05-02-2026
BNB PLUS CORP. filed an 8-K on 2026-02-05 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details on the affected officer, position, appointment/resignation status, reasons, or timing are NOT_DISCLOSED.
05-02-2026
The company filed an 8-K on 2026-02-05 (AccNo: 0000052827-26-000021, Size: 249 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The event is dated February 05, 2026, with event type 'Officer Change'; no additional details such as position, individual, reason, or impacts are provided.
- ·File size: 249 KB
- ·Sector: NOT_DISCLOSED
05-02-2026
Granite Ridge Resources, Inc. filed an 8-K on 2026-02-05 disclosing an officer or director change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on affected positions, individuals, reasons, timing, or impacts are disclosed.
05-02-2026
Fidelity Ethereum Fund filed an 8-K on February 05, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, timing, or impacts are disclosed. This is a standard governance disclosure with no quantitative metrics or further context provided.
05-02-2026
BOSTON SCIENTIFIC CORP filed an 8-K on 2026-02-05 under Item 5.02 disclosing departure of directors or certain officers; election of directors; appointment of certain officers; or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or any financial metrics are disclosed. This represents a standard governance event with no quantified positive or negative impacts provided.
05-02-2026
Fidelity Solana Fund filed an 8-K on February 5, 2026 (AccNo: 0001193125-26-039510), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and other events under Item 8.01. No specific details on the key position affected, whether it is an appointment or resignation, reasons for the change, timing, or any quantitative impacts are disclosed. Sector is not specified.
05-02-2026
On February 05, 2026, the company filed a Form 8-K disclosing an officer change or director departure/election/appointment and compensatory arrangements under Item 5.02, alongside shareholder vote results under Item 5.07. No specific details on affected positions, individuals involved, reasons for the change, timing, vote outcomes, or any quantitative data are disclosed in the provided filing information. This is an informational governance filing with no financial metrics or performance comparisons mentioned.
05-02-2026
Limoneira CO filed an 8-K on 2026-02-05 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons, or financial impacts are disclosed.
05-02-2026
Cathay General Bancorp filed an 8-K on February 5, 2026 (AccNo: 0001437749-26-003217, Size: 161 KB), disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions (e.g., CEO, CFO), individuals involved, reasons for change, internal/external status, timing, or any quantitative data such as compensation are explicitly stated. This is an informational governance filing with no disclosed positive or negative metrics.
05-02-2026
Nano Nuclear Energy Inc. filed an 8-K on 2026-02-05 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also references Item 9.01 for Financial Statements and Exhibits. No specific details on the affected officer, position, reason for change, timing, or compensatory terms are disclosed.
05-02-2026
NeoVolta Inc. filed an 8-K on February 5, 2026, under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. No specific details on the affected position, individual names, appointment or resignation status, reasons, or timing were disclosed. No quantitative financial metrics, performance comparisons, or other material data were provided.
05-02-2026
The company filed an 8-K on February 5, 2026 (AccNo: 0001477932-26-000665) under Item 5.02 disclosing an officer change related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details including officer names, positions, reasons for the change, effective dates, or any quantitative data are disclosed. This is purely informational with no indicated positive or negative performance metrics.
05-02-2026
Consumer Portfolio Services, Inc. filed an 8-K on February 5, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). No specific details on positions affected, individuals involved, reasons for the change, or any financial metrics are disclosed. No positive or negative metrics are mentioned.
05-02-2026
Hilltop Holdings Inc. filed an 8-K on 2026-02-05 disclosing officer or director changes under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on the key position affected, individuals involved, reasons for the change, timing, or any quantitative data such as compensation amounts are disclosed. This appears to be a routine governance disclosure with no mentioned financial metrics or performance impacts.
05-02-2026
Post Holdings, Inc. filed an 8-K on 2026-02-05 disclosing results of operations and financial condition under Item 2.02, departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements under Item 5.02, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details on officer positions affected, reasons for change, financial metrics, or performance comparisons are provided. All quantitative data and named individuals involved are NOT_DISCLOSED.
05-02-2026
CaliberCos Inc. filed an 8-K on 2026-02-05 disclosing Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 5.07 (Submission of Matters to a Vote of Security Holders), and Item 9.01 (Financial Statements and Exhibits). Specific details on affected positions, reasons for changes, vote outcomes, amendment descriptions, or any quantitative metrics are NOT_DISCLOSED. No positive or negative performance metrics are mentioned.
05-02-2026
Blink Charging Co. filed an 8-K on 2026-02-05 disclosing officer or director changes under Item 5.02, including departures, elections, appointments, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, individuals, reasons, or quantitative impacts are disclosed.
05-02-2026
Kaival Brands Innovations Group, Inc. filed an 8-K on 2026-02-05 under Item 5.02 disclosing departure of directors or certain officers, election or appointment of directors or officers, and compensatory arrangements of certain officers. The filing also covers Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year, and Item 9.01 financial statements and exhibits. No specific details on affected positions, individuals, reasons for changes, quantitative data, or scheduled events are disclosed.
05-02-2026
Fluor Corp filed a Form 8-K on 2026-02-05 under Item 5.02 disclosing a change involving the departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as names, titles, reasons for the change, timing, or financial terms are provided in the available information. This appears to be a standard governance disclosure with no quantitative metrics or performance impacts mentioned.
05-02-2026
Wellgistics Health, Inc. filed an 8-K on February 5, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals, reasons for changes, or quantitative impacts are disclosed.
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 54 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC
March 24, 2026
US Corporate Distress Financial Stress SEC Filings — March 24, 2026
US Corporate Distress Financial Stress SEC Filings